Genelux Statistics
Total Valuation
Genelux has a market cap or net worth of $75.92 million. The enterprise value is $58.66 million.
| Market Cap | 75.92M |
| Enterprise Value | 58.66M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Genelux has 34.35 million shares outstanding. The number of shares has increased by 37.16% in one year.
| Shares Outstanding | 34.35M |
| Shares Change (YoY) | +37.16% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 17.53% |
| Owned by Institutions (%) | 17.86% |
| Float | 21.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9,489.73 |
| Forward PS | n/a |
| PB Ratio | 5.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7,332.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.72 |
| Quick Ratio | n/a |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -858.43 |
Financial Efficiency
Return on equity (ROE) is -127.60% and return on invested capital (ROIC) is -147.91%.
| Return on Equity (ROE) | -127.60% |
| Return on Assets (ROA) | -87.40% |
| Return on Capital (ROIC) | -147.91% |
| Revenue Per Employee | $348 |
| Profits Per Employee | -$1.12M |
| Employee Count | 23 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.85% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -91.85% |
| 50-Day Moving Average | 2.76 |
| 200-Day Moving Average | 8.85 |
| Relative Strength Index (RSI) | 44.53 |
| Average Volume (20 Days) | 345,717 |
Short Selling Information
The latest short interest is 1.66 million, so 4.82% of the outstanding shares have been sold short.
| Short Interest | 1.66M |
| Short Previous Month | 1.69M |
| Short % of Shares Out | 4.82% |
| Short % of Float | 7.74% |
| Short Ratio (days to cover) | 5.41 |
Income Statement
In the last 12 months, Genelux had revenue of $8,000 and -$25.78 million in losses. Loss per share was -$0.97.
| Revenue | 8,000 |
| Gross Profit | 8,000 |
| Operating Income | -25.82M |
| Pretax Income | -25.78M |
| Net Income | -25.78M |
| EBITDA | -25.42M |
| EBIT | -25.75M |
| Loss Per Share | -$0.97 |
Balance Sheet
The company has $19.63 million in cash and $2.37 million in debt, giving a net cash position of $17.26 million or $0.50 per share.
| Cash & Cash Equivalents | 19.63M |
| Total Debt | 2.37M |
| Net Cash | 17.26M |
| Net Cash Per Share | $0.50 |
| Equity (Book Value) | 15.08M |
| Book Value Per Share | 0.44 |
| Working Capital | 13.40M |
Cash Flow
In the last 12 months, operating cash flow was -$20.04 million and capital expenditures -$946,000, giving a free cash flow of -$20.99 million.
| Operating Cash Flow | -20.04M |
| Capital Expenditures | -946,000 |
| Free Cash Flow | -20.99M |
| FCF Per Share | -$0.78 |
Margins
Gross margin is 100.00%, with operating and profit margins of -322,725.00% and -322,287.50%.
| Gross Margin | 100.00% |
| Operating Margin | -322,725.00% |
| Pretax Margin | -322,287.50% |
| Profit Margin | -322,287.50% |
| EBITDA Margin | -317,800.00% |
| EBIT Margin | -321,912.50% |
| FCF Margin | -262,312.50% |
Dividends & Yields
Genelux does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.16% |
| Shareholder Yield | -37.16% |
| Earnings Yield | -33.96% |
| FCF Yield | -27.64% |
Analyst Forecast
The average price target for Genelux is $32.33, which is 1,362.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.33 |
| Price Target Difference | 1,362.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 301.23% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Genelux has an Altman Z-Score of -11.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.06 |
| Piotroski F-Score | 2 |